| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |